Antibody-drug conjugates targeting the tyrosine kinase-like orphan receptor 1

TW202641597APending Publication Date: 2026-10-16CHIA TAI TIANQING PHARMA GRP CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW115101204
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-01-14
Filing Date
2026-01-13
Publication Date
2026-10-16

Smart Images

  • Figure TWG2TA001080930_001
    Figure TWG2TA001080930_001
  • Figure TWG2TA001080930_002
    Figure TWG2TA001080930_002
  • Figure TWG2TA001080930_003
    Figure TWG2TA001080930_003
Patent Text Reader

Abstract

This invention belongs to the field of biomedicine and provides an antibody-drug conjugate targeting the tyrosine kinase-like orphan receptor 1, wherein the antibody-drug conjugate comprises a linked antibody, a linker, and a cytotoxic drug. Pharmaceutical compositions comprising the antibody-drug conjugate and their uses are also provided. The provided antibody-drug conjugate achieves excellent antitumor activity and / or good safety. The provided antibody-drug conjugate can be used for the treatment of tumors.
Need to check novelty before this filing date? Find Prior Art